Combined detection of aneuploid circulating tumor-derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non-small-cell lung cancer.
Yuanyuan LeiNan SunGuochao ZhangChengming LiuZhiliang LuJianbing HuangChaoqi ZhangRuochuan ZangYun CheShuangshuang MaoLingling FangXinfeng WangSufei ZhengJie HePublished in: Clinical and translational medicine (2020)
Combined detection of the specific subtypes of aneuploid CD31+ CTECs and CD31- CTCs may help to effectively identify malignant nodules with a higher sensitivity and specificity in early stage NSCLC patients.
Keyphrases
- circulating tumor cells
- early stage
- circulating tumor
- endothelial cells
- end stage renal disease
- small cell lung cancer
- ejection fraction
- newly diagnosed
- loop mediated isothermal amplification
- chronic kidney disease
- sentinel lymph node
- real time pcr
- peritoneal dialysis
- squamous cell carcinoma
- prognostic factors
- radiation therapy
- lymph node
- high glucose
- rectal cancer